$PTPI
Petros Pharmaceuticals, Inc.

2021 Form 10-K Financial Statement

#000141057822000783 Filed on March 31, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $7.811M $9.559M $9.559M
YoY Change -18.29% -38.63% -38.64%
Cost Of Revenue $1.600M $4.046M $4.046M
YoY Change -60.47% -45.52% -45.54%
Gross Profit $6.212M $5.513M $5.513M
YoY Change 12.67% -32.36% -32.36%
Gross Profit Margin 79.52% 57.67% 57.67%
Selling, General & Admin $15.59M $15.67M $15.67M
YoY Change -0.52% -20.54% -20.55%
% of Gross Profit 251.03% 284.33% 284.33%
Research & Development $1.788M $459.6K
YoY Change 289.11%
% of Gross Profit 28.79% 8.34%
Depreciation & Amortization $6.878M $3.330M $6.660M
YoY Change 3.27% 24.25% 25.91%
% of Gross Profit 110.73% 60.4% 120.81%
Operating Expenses $24.26M $22.80M $22.80M
YoY Change 6.43% -8.89% -8.89%
Operating Profit -$18.05M -$17.28M -$17.28M
YoY Change 4.43% 2.45% 2.44%
Interest Expense $9.061M -$4.731M -$4.730M
YoY Change -291.57% -65.83% -65.82%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$8.987M -$22.01M -$22.01M
YoY Change -59.18% -33.61% -33.62%
Income Tax $0.00 -$1.427M -$1.427M
% Of Pretax Income
Net Earnings -$8.987M -$20.59M -$20.59M
YoY Change -56.35% -36.68% -36.68%
Net Earnings / Revenue -115.05% -215.35% -215.35%
Basic Earnings Per Share -$0.83 -$3.85
Diluted Earnings Per Share -$0.83 -$2.121M -$3.85
COMMON SHARES
Basic Shares Outstanding 10.89M 5.341M
Diluted Shares Outstanding 10.89M 5.341M

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.85M $17.14M $17.14M
YoY Change 39.13% 697.21%
Cash & Equivalents $17.14M
Short-Term Investments $0.00 $0.00 $0.00
Other Short-Term Assets $3.720M $114.8K $2.850M
YoY Change 30.53% -44.44%
Inventory $519.6K $760.5K $760.0K
Prepaid Expenses
Receivables $2.455M $5.153M $5.150M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $30.54M $25.91M $25.91M
YoY Change 17.88% 114.31%
LONG-TERM ASSETS
Property, Plant & Equipment $525.0K $64.25K $640.0K
YoY Change -17.98% -13.51%
Goodwill
YoY Change
Intangibles $32.16M
YoY Change
Long-Term Investments
YoY Change
Other Assets $11.03M $579.5K $11.14M
YoY Change -0.99% 65.53%
Total Long-Term Assets $36.85M $43.95M $43.94M
YoY Change -16.14% -5.06%
TOTAL ASSETS
Total Short-Term Assets $30.54M $25.91M $25.91M
Total Long-Term Assets $36.85M $43.95M $43.94M
Total Assets $67.39M $69.85M $69.85M
YoY Change -3.52% 19.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.558M $5.610M $5.610M
YoY Change -18.75% 48.41%
Accrued Expenses $23.54M $14.68M $26.73M
YoY Change -11.93% 13.07%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $7.175M $7.180M
YoY Change -100.0% 7.49%
Total Short-Term Liabilities $30.98M $41.89M $41.89M
YoY Change -26.04% 1.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $865.0K $600.9K $10.49M
YoY Change -91.75% 1298.67%
Total Long-Term Liabilities $865.0K $600.9K $10.49M
YoY Change -91.75% 34.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $30.98M $41.89M $41.89M
Total Long-Term Liabilities $865.0K $600.9K $10.49M
Total Liabilities $31.85M $52.38M $52.38M
YoY Change -39.2% 4.03%
SHAREHOLDERS EQUITY
Retained Earnings -$61.70M
YoY Change
Common Stock $971.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $35.54M $17.47M $17.47M
YoY Change
Total Liabilities & Shareholders Equity $67.39M $69.85M $69.85M
YoY Change -3.52% 19.67%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$8.987M -$20.59M -$20.59M
YoY Change -56.35% -36.68% -36.68%
Depreciation, Depletion And Amortization $6.878M $3.330M $6.660M
YoY Change 3.27% 24.25% 25.91%
Cash From Operating Activities -$11.86M -$7.190M -$15.31M
YoY Change -22.5% 912.68% -704.95%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $4.633K
YoY Change -100.0% -100.0% -106.62%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 -$4.633K
YoY Change -100.0% -100.0% -93.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $21.75M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 18.57M 23.49M 30.30M
YoY Change -38.72% -12463.16% -1074.4%
NET CHANGE
Cash From Operating Activities -11.86M -7.190M -15.31M
Cash From Investing Activities 0.000 0.000 -4.633K
Cash From Financing Activities 18.57M 23.49M 30.30M
Net Change In Cash 6.708M 16.30M 14.99M
YoY Change -55.26% -1780.41% -2406.75%
FREE CASH FLOW
Cash From Operating Activities -$11.86M -$7.190M -$15.31M
Capital Expenditures $0.00 $0.00 $4.633K
Free Cash Flow -$11.86M -$7.190M -$15.31M
YoY Change -22.52% 1023.44% -688.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.85
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10889766
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5340682
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10889766
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5340682
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001815903
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
500
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20684723
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9707655
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.85
CY2020Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12180037
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39752
CY2021 dei Entity Registrant Name
EntityRegistrantName
PETROS PHARMACEUTICALS, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1410058
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1185 Avenue of the Americas
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
3rd Floor
CY2021Q4 ptpi Accrued Inventory Purchases
AccruedInventoryPurchases
14203905
CY2020Q4 ptpi Accrued Inventory Purchases
AccruedInventoryPurchases
14203905
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
260818
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
221766
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
30980076
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
CY2021 dei City Area Code
CityAreaCode
973
CY2021 dei Local Phone Number
LocalPhoneNumber
242-0005
CY2021 dei Security12b Title
Security12bTitle
Common Stock
CY2021 dei Trading Symbol
TradingSymbol
PTPI
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
20060345
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20684723
CY2021 dei Auditor Firm
AuditorFirmId
274
CY2021 dei Auditor Name
AuditorName
EisnerAmper LLP
CY2021 dei Auditor Location
AuditorLocation
Iselin, New Jersey
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23847572
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17139694
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2455386
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5152969
CY2021Q4 us-gaap Inventory Net
InventoryNet
519649
CY2020Q4 us-gaap Inventory Net
InventoryNet
760530
CY2020Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4576
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
3720088
CY2020Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2847284
CY2021Q4 us-gaap Assets Current
AssetsCurrent
30542695
CY2020Q4 us-gaap Assets Current
AssetsCurrent
25905053
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49397
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
64250
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25293149
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
32160919
CY2021Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
11029260
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
11144257
CY2021Q4 us-gaap Other Assets
OtherAssets
475557
CY2020Q4 us-gaap Other Assets
OtherAssets
579535
CY2021Q4 us-gaap Assets
Assets
67390058
CY2020Q4 us-gaap Assets
Assets
69854014
CY2020Q4 us-gaap Debt Current
DebtCurrent
7175029
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
4557969
CY2020Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
5609556
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11957384
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14683786
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
500
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
41894042
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
460000
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
9890000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
405018
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
600920
CY2021Q4 us-gaap Liabilities
Liabilities
31845094
CY2020Q4 us-gaap Liabilities
Liabilities
52384962
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20684723
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9707655
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2068
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
971
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
106231716
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
79170225
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70688820
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61702144
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
35544964
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
17469052
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67390058
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69854014
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7811264
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9559469
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1599566
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4046466
CY2021 us-gaap Gross Profit
GrossProfit
6211698
CY2020 us-gaap Gross Profit
GrossProfit
5513003
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15593233
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15674968
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1788491
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
459636
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6877990
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6660438
CY2021 us-gaap Operating Expenses
OperatingExpenses
24259714
CY2020 us-gaap Operating Expenses
OperatingExpenses
22795042
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-18048016
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-17282039
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
9430000
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1680000
CY2021 ptpi Interest Expense Senior Debt
InterestExpenseSeniorDebt
368660
CY2020 ptpi Interest Expense Senior Debt
InterestExpenseSeniorDebt
1323424
CY2020 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
1727455
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
17469052
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8986676
CY2020 ptpi Net Proceeds Received From Recapitalization For Mergers Value
NetProceedsReceivedFromRecapitalizationForMergersValue
20997750
CY2020 ptpi Adjustments To Additional Paid In Capital Bifurcation Of Derivative Liability Related To Merger Contingent Consideration
AdjustmentsToAdditionalPaidInCapitalBifurcationOfDerivativeLiabilityRelatedToMergerContingentConsideration
-8209998
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-20585925
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22012918
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1426993
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-8986676
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-20585925
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.85
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10889766
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5340682
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
8019219
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
17227455
CY2020 ptpi Warrants Exercised During Period Value
WarrantsExercisedDuringPeriodValue
20551
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21745003
CY2021 ptpi Warrants Exercised During Period Value
WarrantsExercisedDuringPeriodValue
4012435
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1117348
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
187802
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-8986676
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
35544964
CY2021 us-gaap Profit Loss
ProfitLoss
-8986676
CY2020 us-gaap Profit Loss
ProfitLoss
-20585925
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6877990
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6660438
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
148885
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
202525
CY2021 ptpi Inventory And Sample Inventory Reserve
InventoryAndSampleInventoryReserve
-200251
CY2020 ptpi Inventory And Sample Inventory Reserve
InventoryAndSampleInventoryReserve
1752041
CY2020 ptpi Non Cash Paid In Kind Interest
NonCashPaidInKindInterest
1771904
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
12500
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
37500
CY2020 us-gaap Accretion Expense
AccretionExpense
116196
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1432166
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
103978
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
92711
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
9430000
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1680000
CY2021 ptpi Adjustments For Deferred Revenue
AdjustmentsForDeferredRevenue
70343
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1117348
CY2021 ptpi Non Employee Stock Based Compensation
NonEmployeeStockBasedCompensation
187802
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2548698
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2750364
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-412744
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-728286
CY2021 ptpi Increase Decrease In Deposits1
IncreaseDecreaseInDeposits1
4576
CY2020 ptpi Increase Decrease In Deposits1
IncreaseDecreaseInDeposits1
1734
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
724785
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1031108
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1051587
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2222114
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2726403
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6203476
CY2020 ptpi Increase Decrease In Accrued Inventory Purchases
IncreaseDecreaseInAccruedInventoryPurchases
-250000
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-31291
CY2020 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-231325
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-195902
CY2020 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-148626
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11862031
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15305325
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4633
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4633
CY2020 ptpi Proceeds Received From Recapitalization From Mergers
ProceedsReceivedFromRecapitalizationFromMergers
22592285
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1042910
CY2021 us-gaap Repayments Of Debt
RepaymentsOfDebt
6653292
CY2020 us-gaap Repayments Of Debt
RepaymentsOfDebt
6181711
CY2021 ptpi Payment Of Senior Debt End Of Term Fee
PaymentOfSeniorDebtEndOfTermFee
-534237
CY2020 ptpi Payment Of Senior Debt End Of Term Fee
PaymentOfSeniorDebtEndOfTermFee
-534375
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
50000
CY2020 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
15500000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
21745003
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4012435
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
20551
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18569909
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30303840
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6707878
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14993882
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17139694
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2145812
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23847572
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17139694
CY2021 us-gaap Interest Paid Net
InterestPaidNet
421821
CY2020 us-gaap Interest Paid Net
InterestPaidNet
1191400
CY2021 ptpi Noncash Decrease In Api Purchase Commitment
NoncashDecreaseInApiPurchaseCommitment
114997
CY2021 ptpi Noncash Decrease In Other Current Assets Api Purchase Commitment
NoncashDecreaseInOtherCurrentAssetsApiPurchaseCommitment
-114997
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
17227455
CY2020 ptpi Noncash Increase In Api Inventory Other Assets
NoncashIncreaseInApiInventoryOtherAssets
5148311
CY2020 ptpi Deferred Merger Costs Reclassified To Additional Paid In Capital
DeferredMergerCostsReclassifiedToAdditionalPaidInCapital
551625
CY2020Q4 ptpi Cash In Excess Of Certain Limit Subject To Adjustment As Provided In Merger Agreement
CashInExcessOfCertainLimitSubjectToAdjustmentAsProvidedInMergerAgreement
20000000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23800000
CY2021Q4 ptpi Working Capital
WorkingCapital
400000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70700000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the Consolidated Financial Statements and reported amounts of revenue and expenses during the reporting periods. Such estimates include the adequacy of accounts receivable reserves, return reserves, inventory reserves, assessment of long-lived assets, including intangible asset impairment, the allocation of the purchase price in acquisitions and the valuation of the derivative liability, among others. Actual results could differ from these estimates and changes in these estimates are recorded when known.</p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that subject the Company to concentrations of credit risk includes cash. The Company maintains cash on deposit at U.S.-based banks in amounts which, at times, may be in excess of insured limits.</p>
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
3800000
CY2020Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
7100000
CY2021 us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2021Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
500000
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
9900000
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020 ptpi Shipping Costs
ShippingCosts
0
CY2021 ptpi Shipping Costs
ShippingCosts
0
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
3363827
CY2020Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
6560291
CY2021Q4 ptpi Accounts Receivable Distribution Service Fees
AccountsReceivableDistributionServiceFees
371310
CY2020Q4 ptpi Accounts Receivable Distribution Service Fees
AccountsReceivableDistributionServiceFees
972652
CY2020Q4 ptpi Accounts Receivable Chargebacks Accruals
AccountsReceivableChargebacksAccruals
121269
CY2021Q4 ptpi Accounts Receivable Cash Discount Allowances
AccountsReceivableCashDiscountAllowances
159446
CY2020Q4 ptpi Accounts Receivable Cash Discount Allowances
AccountsReceivableCashDiscountAllowances
84601
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
377685
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
228800
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
2455386
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
5152969
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
359741
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
325932
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
159908
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
434598
CY2021Q4 us-gaap Inventory Gross
InventoryGross
519649
CY2020Q4 us-gaap Inventory Gross
InventoryGross
760530
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
383298
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
935866
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2872977
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2872977
CY2020Q4 ptpi Prepaid Samples Current
PrepaidSamplesCurrent
58483
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
73223
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
149452
CY2021Q4 ptpi Prepaid Food And Drug Administration Fee Current
PrepaidFoodAndDrugAdministrationFeeCurrent
831179
CY2020Q4 ptpi Prepaid Food And Drug Administration Fee Current
PrepaidFoodAndDrugAdministrationFeeCurrent
756972
CY2021Q4 ptpi Prepaid Coupon Fee Current
PrepaidCouponFeeCurrent
71500
CY2020Q4 ptpi Prepaid Coupon Fee Current
PrepaidCouponFeeCurrent
71500
CY2021Q4 ptpi Prepaid Purchase Commitment Asset Current
PrepaidPurchaseCommitmentAssetCurrent
1419538
CY2020Q4 ptpi Prepaid Purchase Commitment Asset Current
PrepaidPurchaseCommitmentAssetCurrent
1304541
CY2021Q4 ptpi Due From Wholesalers Current
DueFromWholesalersCurrent
609059
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
605422
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
391552
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
110167
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
114784
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3720088
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2847284
CY2021Q4 ptpi Prepaid Samples Net Of Reserves
PrepaidSamplesNetOfReserves
0
CY2020Q4 ptpi Prepaid Samples Net Of Reserves
PrepaidSamplesNetOfReserves
351224
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
38811137
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-6650218
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
32160919
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-6867770
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25293149
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6191740
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5445729
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4650787
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2716011
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2201720
CY2021Q4 ptpi Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
4087162
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25293149
CY2021Q4 ptpi Accrued Price Protection
AccruedPriceProtection
1853979
CY2020Q4 ptpi Due Under License Agreement
DueUnderLicenseAgreement
2267523
CY2021Q4 ptpi Due To Third Party Logistic Provider
DueToThirdPartyLogisticProvider
479178
CY2020Q4 ptpi Accrued Price Protection
AccruedPriceProtection
1853979
CY2021Q4 ptpi Accrued Product Returns
AccruedProductReturns
6192845
CY2020Q4 ptpi Accrued Product Returns
AccruedProductReturns
9452248
CY2021Q4 ptpi Accrued Contract Rebates
AccruedContractRebates
379242
CY2020Q4 ptpi Accrued Contract Rebates
AccruedContractRebates
412046
CY2021Q4 ptpi Due Under License Agreement
DueUnderLicenseAgreement
2267523
CY2020Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
12500
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
296000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
519609
CY2021Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
527563
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
125392
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
131662
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
178381
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11957384
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14683786
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7175029
CY2021Q4 us-gaap Repayments Of Debt
RepaymentsOfDebt
1179651
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.38
CY2021 ptpi Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P9Y2M23D
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6653292
CY2020Q4 ptpi Debt Instrument End Of Term Charge
DebtInstrumentEndOfTermCharge
534237
CY2021 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
356160
CY2020 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1241475
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
12500
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
37500
CY2020 us-gaap Paid In Kind Interest
PaidInKindInterest
44449
CY2021 ptpi Interest Expense Senior Debt
InterestExpenseSeniorDebt
368660
CY2020 ptpi Interest Expense Senior Debt
InterestExpenseSeniorDebt
1323424
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
65885
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2020 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
1727455
CY2021Q4 ptpi Common Stock Potentially Issuable Upon Achievement Of Certain Milestones
CommonStockPotentiallyIssuableUponAchievementOfCertainMilestones
14232090
CY2021 ptpi Milestones Term For Achievement Of Stock Price And Market Capitalization
MilestonesTermForAchievementOfStockPriceAndMarketCapitalization
P2Y
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Shares Period Increase Decrease
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease
1521654
CY2021Q4 ptpi Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Issuance
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForIssuance
2600000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2600000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1867948
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
574331
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
51.43
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y10M24D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
574331
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
51.43
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
615669
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.38
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
574331
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y2M23D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
277835
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.40
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y2M23D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
51.43
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y10M24D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
615669
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.21
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.30
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P2Y
CY2021 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
1305150
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4407962
CY2020Q4 ptpi Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
0
CY2020Q4 ptpi Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0
CY2020Q4 ptpi Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
0
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4407962
CY2021 ptpi Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
7853558
CY2021 ptpi Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
-2014586
CY2021 ptpi Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
-207913
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10039021
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10039021
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10889766
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5340682
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-8986676
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-20585925
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.85
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10771073
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4982293
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
179246
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
179246
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
475557
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
579535
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
125579
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
108971
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
530597
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
405018
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
530597
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
639568
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y8M8D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y8M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.126
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.126
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
184239
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
182639
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
187739
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
189374
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
155242
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
81107
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
82324
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
695787
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
165190
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
530597
CY2021Q4 ptpi Security Deposit For Sub Lease Received
SecurityDepositForSubLeaseReceived
14000
CY2021Q4 ptpi Operating Lease Expense Per Month
OperatingLeaseExpensePerMonth
7000
CY2021Q4 ptpi Lessee Operating Lease Lease Not Yet Commenced Amount
LesseeOperatingLeaseLeaseNotYetCommencedAmount
0
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
5085
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
88
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
5173
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1378731
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-53435
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1432166
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1426993
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.0061
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0156
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.2231
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0268
CY2021 ptpi Effective Income Tax Rate Reconciliation Recapitalization
EffectiveIncomeTaxRateReconciliationRecapitalization
0.0000
CY2020 ptpi Effective Income Tax Rate Reconciliation Recapitalization
EffectiveIncomeTaxRateReconciliationRecapitalization
0.3649
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.0000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.3271
CY2021 ptpi Effective Income Tax Rate Reconciliation Book Income Rtp
EffectiveIncomeTaxRateReconciliationBookIncomeRtp
7.43
CY2020 ptpi Effective Income Tax Rate Reconciliation Book Income Rtp
EffectiveIncomeTaxRateReconciliationBookIncomeRtp
0.00
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.5555
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1722
CY2021 ptpi Effective Income Tax Rate Reconciliation Adjustment To Opening Deferrals
EffectiveIncomeTaxRateReconciliationAdjustmentToOpeningDeferrals
5.42
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6877990
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
9430000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
459636
CY2020 ptpi Effective Income Tax Rate Reconciliation Adjustment To Opening Deferrals
EffectiveIncomeTaxRateReconciliationAdjustmentToOpeningDeferrals
0.00
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0644
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
186739
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
90222
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1006954
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1238128
CY2021Q4 ptpi Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
5669065
CY2020Q4 ptpi Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
5661235
CY2021Q4 ptpi Deferred Tax Assets Expenses Non Currently Deductible
DeferredTaxAssetsExpensesNonCurrentlyDeductible
815108
CY2020Q4 ptpi Deferred Tax Assets Expenses Non Currently Deductible
DeferredTaxAssetsExpensesNonCurrentlyDeductible
148708
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3702789
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
57266
CY2021Q4 ptpi Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
96920
CY2020Q4 ptpi Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
25547
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2716370
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2505425
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12180037
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
7250275
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
17400000
CY2021 ptpi Percentage Of Future Utilization Of Operating Loss Carryforwards
PercentageOfFutureUtilizationOfOperatingLossCarryforwards
0.80
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
57543
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
116364
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7811264
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1599566
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15593233
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1788491
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
368660
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-8986676
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6660438
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9559469
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4046466
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15674968
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1680000
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
3050879
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1426993
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-20585925
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7811264
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
32160919
CY2020Q4 us-gaap Assets
Assets
69854014
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9559469
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
25293149
CY2021Q4 us-gaap Assets
Assets
67390058

Files In Submission

Name View Source Status
0001410578-22-000783-index-headers.html Edgar Link pending
0001410578-22-000783-index.html Edgar Link pending
0001410578-22-000783.txt Edgar Link pending
0001410578-22-000783-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20211231.xsd Edgar Link pending
tmb-20211231x10k.htm Edgar Link pending
tmb-20211231x10k_htm.xml Edgar Link completed
tmb-20211231xex21.htm Edgar Link pending
tmb-20211231xex23d1.htm Edgar Link pending
tmb-20211231xex31d1.htm Edgar Link pending
tmb-20211231xex31d2.htm Edgar Link pending
tmb-20211231xex32.htm Edgar Link pending
tmb-20211231xex4d4.htm Edgar Link pending
tmb-20211231_cal.xml Edgar Link unprocessable
tmb-20211231_def.xml Edgar Link unprocessable
tmb-20211231_lab.xml Edgar Link unprocessable
tmb-20211231_pre.xml Edgar Link unprocessable